Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Master’s student awarded Mandela Rhodes scholarship
2015-11-25

 

Candice Thikeson’s name will be added to the Mandela Rhodes Scholars book
Photo: Valentino Ndaba

Candice Thikeson was recently selected as the only 2016 Mandela Rhodes Scholar from the University of the Free State. She is one of 50 young African postgraduate students, eager to contribute positively to the educational development of the continent.

The Mandela Rhodes scholarship is a fully-funded postgraduate scholarship awarded to promising future leaders by the Mandela Rhodes Foundation. It is named after the former president of our country, Nelson Mandela, and Cecil Rhodes, who was known for his business skills and political influence in South Africa. Instituted in 1999, the scholarship aims to advance scholars who demonstrate the principles of Leadership and Reconciliation embodied by Mandela and Rhodes’s legacy, as they relate specifically to Education and Entrepreneurship.

Thikeson expects the programme will educate her on how to integrate the four pillars in relation to her field of study.

For Thikeson, earning the scholarship served as an endorsement of her dream of becoming an academic. “I want to obtain a PhD, lecture at a university, publish papers, and speak at conferences,” she related. “I also want to produce academics, I want to mentor young people,” she added.

Her academic journey began in 2011 when she pursued a BA Fine Arts degree for a year. Thikeson then transferred to a BA General degree which she completed over two instead of the standard three years. She went on to study an Honours degree in Art History and Visual Culture Studies. In the same year, she travelled to Rijksuniversiteit Groningen (University of Groningen) in the Netherlands as part of an exchange agreement between the university and the UFS, where she completed her mini-dissertation in four months. Both her BA and Honours were passed with distinction. Currently, Thikeson is pursuing a Masters degree at the Department of Art History and Image Studies under the supervision of Prof Suzanne Human.

Some accolades to her name include the Jan Teurlinckx Prize for the best student in Art History (2011), the David Jacobs Prize, awarded to the best student in Philosophy (2013), and the Richard Miles Prize, presented by the Dean of the Faculty of the Humanities (2013). Thikeson was also selected as a member of the Golden Key Honour society in 2012, for her consistent academic excellence.

Last year, Lehlohonolo Mofokeng, Zola Valashiya, and Tumelo Morobane made the UFS proud by graduating as the class of 2015 Mandela Rhodes Scholars.

 

 

 

 

 

 

 

 

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept